At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Nov 4, 2026 at 08:00 ET
ZUSDURI revenue grew 35% QoQ to $68.0M, but JELMYTO revenue declined to $21.0M and full-year JELMYTO guidance was lowered to ~$90M from $97-101M. The FDA accepted the UGN-103 NDA with a PDUFA date of June 14, 2027.
- Total revenue $89.0M vs. $89.9M consensus (slight miss)
- ZUSDURI net product revenue $68.0M, up 35% QoQ
- JELMYTO net product revenue $21.0M, down from $25.7M YoY
- Full-year 2026 JELMYTO revenue guidance lowered to ~$90M from $97-101M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access